Vitamin D Supplementation in Children
MeltD
Effectiveness of Vitamin D Supplementation in the Prevention of Vitamin D Deficiency in Children.
1 other identifier
interventional
73
1 country
1
Brief Summary
Prevalence of vitamin D deficiency in children in the northern country during winter season is very high (up to 90%). Vitamin D supplementation at a dose 600 -1000 IU/d is recommended in Polish children from September till April. However, there is shortage of studies in Polish children. The aim of the study is to assess the effectiveness of vitamin D supplementation in the prevention of vitamin D deficiency in Polish children (4-10 years of age).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 9, 2018
CompletedFirst Submitted
Initial submission to the registry
January 11, 2018
CompletedFirst Posted
Study publicly available on registry
January 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 26, 2018
CompletedJune 19, 2018
June 1, 2018
5 months
January 11, 2018
June 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
serum 25-hydroxyvitamin D level
after intervension vs baseline level
during 3 months of vitamin D supplementation
Secondary Outcomes (2)
prevalence of vitamin D deficiency
during 3 months of vitamin D supplementation
prevalence of vitamin D suficiency
during 3 months of vitamin D supplementation
Study Arms (1)
cholecalciferol
EXPERIMENTALcholecalciferol at a dose 1000 IU /day for 3 months
Interventions
Eligibility Criteria
You may qualify if:
- Age 4-10 years; declaration of no use other preparations containing vitamin D; parental written informed consent
You may not qualify if:
- Osteoporosis, autoimmunological disorders, sarcoidosis, exacerbation of asthma, hypercalcemia, nephrolithiasis, renal insufficiency, nephrotic syndrome, cholestasis, hepatitis, diabetes typ 1, anticonvulsant treatment, prolonged treatment with steroids, cimetidine, ketoconazole, teophiline, diuretics, anti-tuberculosis drugs, participation in another clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Memorial Health Institute, Polandlead
- Nutropharma Ltd.collaborator
Study Sites (1)
The Children's Memorial Health Institute
Warsaw, 04-730, Poland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Justyna Czech-Kowalska
The Children's Memorial Health Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Head of Neonatal Department
Study Record Dates
First Submitted
January 11, 2018
First Posted
January 18, 2018
Study Start
January 9, 2018
Primary Completion
May 26, 2018
Study Completion
May 26, 2018
Last Updated
June 19, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share